Skip to main content

Initiative Covid-19 Technology Access Pool (C-TAP)

We are thrilled that last week our member Medigen Vaccine Biologics Corp (MVC) accomplished a significant move towards equitable global vaccine distribution!
MVC announced an out-licensing agreement with the World Health Organization‘s COVID-19 Technology Access Pool (C-TAP) initiative and its implementation partner Medicines Patent Pool. Through the C-TAP initiative, MVC will out-license its COVID-19 vaccine, its technology and critical know-how and provide training to licensees, fostering widespread availability and accessibility of life-saving vaccination technology worldwide.  The agreement will enable licensing of IP facilitating technology transfer and staff training. This makes MVC the first private manufacturer to out-license COVID-19 vaccine technology and know-how!